Sensitive developmental periods for kanamycin ototoxic effects on distortion-product otoacoustic emissions

Hearing Research

Volumn 98, Issue 1-2, 1996, Pages 93-103

  Henley, Charles M ^a   Weatherly, Robert A ^b   Martin, Glen K ^c   Lonsbury Martin, Brenda ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MIAMI EAR INSTITUTE   (United States)

Author keywords

Distortion product emission; Kanamycin; Neonatal rat; Ototoxicity

Indexed keywords

KANAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED OTOACOUSTIC EMISSION; HAIR CELL; INTRAMUSCULAR DRUG ADMINISTRATION; NEWBORN; NONHUMAN; OTOTOXICITY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT;

EID: 0030249331     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5955(96)00077-9     Document Type: Article

References (59)

1. Anniko, M., Thornell, L.-E. and Wroblewski, R. (1988) Recent advances in inner ear cytochemistry-microanalytical and immunomorphological investigations, Prog. Neurobiol. 30, 209-269.
2. Aran, J.M., Erre, J.-P., Guilhaume, A. and Aurousseau, C. (1980) The comparative ototoxicities of gentamicin, tobramycin and dibekacin in the guinea pig. Acta Otorhinolaryngol. Suppl. 390, 1-30.
3. Arpini, A., Cornacchia, L., Albiero, L., Bamonte, F., and Parravicini, L. (1979) Auditory function in guinea pigs treated with netilmicin and other aminoglycoside antibiotics. Arch. Otorhinolaryngol. 224, 137-142.
4. Astbury, P.J. and Read, N.G. (1982) Kanamycin induced ototoxicity in the laboratory rat. Arch. Toxicol. 50, 267-278.
5. Axelsson, A., Ryan, A. and Woolf, N. (1986) The early postnatal development of the cochlear vasculature in the gerbil. Acta Otolaryngol. 101, 75-87.
6. Barza, M. and Scheife, R.T. (1977) Antimicrobial spectrum, pharmacology, and therapeutic use of antibiotics. J. Maine Med. Assoc. 68, 194-210.
7. Bernard, P.A. (1981) Freedom from ototoxicity in aminoglycoside treated neonates: a mistaken notion. Laryngoscope 91, 1985-1994.
8. Bernard, P.A., Pechere, J.C. and Hebert, R. (1980) Altered objective audiometry in aminoglycosides-treated human neonates. Arch. Otorhinolaryngol. 228, 205-210.
9. Brown, A.M. (1989) Acoustic distortion from rodent ears: A comparison of responses from rats, guinea pigs and gerbils. Hear. Res. 31, 25-38.
10. Brown, A.M., McDowell, B. and Forge, A. (1989) Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear. Res. 42, 143-156.
11. Brown, R.D., Henley, C.M., Penny, J.E., and Kupetz, S. (1985) Link between functional and morphological changes in the inner ear: functional changes produced by ototoxic agents and their interactions. Arch. Toxicol. Suppl. 8, 240-250.
12. Carlier, E. and Pujol, R. (1980) Supra-normal sensitivity to ototoxic antibiotic of the developing rat cochlea. Arch. Otorhinolaryngol. 226, 129-133.
13. Crowley, D.E. and Hepp-Reymond, M.-C. (1966) Development of cochlear function in the ear of the infant rat. J. Comp. Physiol. Psychol. 62, 427-432.
14. Dallos, P. and Cheatham, M.A. (1976) Production of cochlear potentials by inner and outer hair cells. J. Acoust. Soc. Am. 60, 510-512.
15. Hawkins, J.E. (1976) Drug ototoxicity. In: Wolf D, Keidel and W.D. Neff (Eds.), Handbook of Sensory Physiology, Vol. 5, Springer, Berlin. pp. 707-748.
16. Henley, C.M. (1991) Postnatal developmental changes in inner ear ornithine decarboxylase (ODC). Hear. Res. 55, 45-49.
17. Henley, C.M. (1994) Kanamycin depletes cochlear polyamines in the developing rat. Oto-Head Neck Surg. 110, 103-109.
18. Henley, C.M. and Rybak, L.P. (1995) Ototoxicity in developing mammals. Brain Res. Rev. 20, 68-90.
19. Henley C.M. and Schacht, J. (1988) Pharmacokinetics of aminoglycoside antibiotics in blood, inner-ear fluids and their relationship to ototoxicity. Audiology 27, 137-146.
20. Henley, C.M., Gerhardt, H.-J. and Schacht, J. (1987) Inhibition of inner ear ornithine decarboxylase by neomycin in vitro. Brain Res. Bull. 19, 695-698.
21. Henley, C.M., Mahran, L.G. and Schacht, J. (1988) Inhibition of renal ornithine decarboxylase by aminoglycoside antibiotics in vitro. Biochem. Pharmacol. 37, 1679-1682.
22. Henley, C.M., Atkins, J., Martin, G.K., and Lonsbury-Martin, B.L. (1990a) Critical period for alpha-difluoromethylornithine (DFMO) ototoxicity in the developing rat. J. Cell. Biochem., Suppl. 14F, 22.
23. 2 otoacoustic emissions in pigmented rat. Hear. Res. 43, 141-148.
24. Henley, C.M., Weatherly, R.A., Ou, C-N and Brown, R.D. (1996) Pharmacokinetics of kanamycin in the developing rat. Hear. Res. 99, in press.
25. Henry, K.R., Chole, R.A., McGinn, M.D., and Frush, D.P. (1981) Increased ototoxicity in both young and old mice. Arch. Otolaryngol. 107, 92-95.
26. Hewitt, W.L. (1974) Gentamicin: toxicity in perspective. Postgrad. Med. J. 50, 55-61.
27. Hudspeth, A.J. and Kroese, A.B.A. (1983) Voltage-dependent interaction of dihydrostreptomycin with the transduction channels in bullfrog sensory hair cells. J. Physiol. (Lond.) 345, 66.
28. Huang, M.Y. and Schacht. J. (1990) Formation of a cytotoxic metabolite from gentamicin by liver. Biochem. Pharmacol. 40, R11-R14.
29. Koitchev, K., Guilhaume, A., Cazals, Y., and Aran, J. (1982) Spiral ganglion changes after massive aminoglycoside treatment in the guinea pig. Acta Otolaryngol. 94, 431-438.
30. Kuijpers, W. (1974) Na-K-ATPase activity in the cochlea of the rat during development. Acta Otolaryngol. (Stoch.) 78, 341-344.
31. 2 otoacoustic emissions in the rat. Hear. Res. 29, 265-271.
32. Lenoir, M., Shnerson, A. and Pujol, R. (1980) Cochlear receptor development in the rat with emphasis on synaptogenesis. Anat. Embryol. 160, 253-262.
33. Lenoir, M., Marot, M., and Uziel, A. (1983) Comparative ototoxicity of four aminoglycoside antibiotics during the critical period of cochlear development in the rat. Acta Otolaryngol. Suppl. 405, 1-16.
34. Lonsbury-Martin, B.L., Martin, G.K., Probst, R. and Coats, A.C. (1987) Acoustic distortion products in rabbit ear canal. I. Basic features and physiological vulnerability. Hear. Res. 28, 173-189.
35. Lyos, A.T., Winter, W.E., Henley, C.M. (1992) Kanamycin inhibits cochlear-renal ODC in neonatal rats. Oto-Head Neck Surg. 107, 501-510.
36. Marot, M., Uziel, A. and Romand, R. (1980) Ototoxicity of kanamycin in developing rats: relationship with the onset of the auditory function. Hear. Res. 2, 111-113.
37. Martin, G.K., Lonsbury-Martin, B.L., Probst. R., Scheinin, S.A. and Coats, A.C. (1987) Acoustic distortion products in rabbit ear canal. II. Sites of origin revealed by suppression contours and pure-tone exposures. Hear. Res. 28, 191-208.
38. Meyer, R.D. (1981) Amikacin. Ann. Intern. Med. 95, 328-332.
39. Norton, S.J., Bargones, J.Y. and Rubel, E.W (1991) Development of otoacoustic emissions in gerbil: evidence for micromechanical changes underlying development of the place code. Hear. Res. 51, 73-92.
40. Onejeme, A.U. and Khan, K.M. (1984) Morphologic study of effects of kanamycin on the developing cochlea of the rat. Teratology 29, 57-71.
41. Osako, S., Tokimoto, T. and Matsuura, S. (1979) Effects of kanamycin on the auditory evoked responses during postnatal development of the hearing of the rat. Acta Otolaryngol. 88, 359-368.
42. Prieve, B.A. and Yanz, J.L. (1984) Age-dependent changes in susceptibility to ototoxic hearing loss. Acta Otolaryngol. 98, 428-438.
43. Puel, J.-L. and Uziel, A. (1987) Correlative development of cochlear action potential sensitivity, latency and frequency selectivity. Dev. Brain Res. 37, 179-188.
44. Pujol, R. (1986) Periods of sensitivity to antibiotic treatment. Acta Otolaryngol. Suppl. 429, 29-33.
45. Pujol, R. and Hilding, D. (1973) Anatomy and physiology of the onset of auditory function. Acta Otolaryngol. 76, 1-10.
46. Pujol, R., Carlier, E. and Lenoir, M. (1980) Ontogenic approach to inner and outer hair cell functions. Hear. Res. 2, 423-430.
47. Pujol, R., Lavigne-Rebillard, M.J. and Uziel, A. (1991) Development of the human cochlea. Acta Otorhinolaryngol. Suppl. 482, 7-12.
48. Russell, D.H. (1985) Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Drug Metab, Rev., 16, 1-88.
49. Rybak, L.P., Whitworth, C., Weberg, A., and Scott, V. (1990) Development of the organ of Corti in the rat. Soc. Neurosci. Abstr. 16, 871.
50. Rybak, L.P., Whitworth, C. and Scott, V. (1992) Development of the endocochlear potential and compound action potential in the rat. Hear. Res. 59, 189-194.
51. Sarrubi, F.A., Jr. and Hull, J.H. (1978) Amikacin serum concentrations: prediction of levels and dosage guidelines. Ann. Intern. Med. 89, 612-618.
52. Schacht, J. (1986) Molecular mechanisms of drug-induced hearing loss. Hear. Res. 22, 297-304.
53. Schacht, J.H. and Weiner, N. (1986) Aminoglycoside-induced hearing loss: a molecular hypothesis. Oto-Rhino-Laryngol. 48, 116-123.
54. Shnerson, A., Devigne, C. and Pujol, R. (1982) Age-related changes in the C57 BL/6J. mouse cochlea. II. Ultrastructural findings. Dev. Brain Res. 2, 77-82.
55. Uziel, A., Romand, R. and Marot, M. (1981) Development of cochlear potentials in the rat. Audiology 20, 89-100.
56. Wästerström, S.A., Bredberg, G., Lindquist, N.G., Lyttkens, L. and Rask-Andersen, H. (1986) Ototoxicity of kanamycin in albino and pigmented guinea pigs. I. A morphologic and electrophysiologic study. Am. J. Otol. 7, 11-18.
57. Wersäll, J. and Flock, Å. (1964) Suppression and restoration of the microphonic output from the lateral line organ after local application of streptomycin. Life Sci. 3, 1151-1155.
58. Williams, S.E., Zenner, H.P. and Schacht. J. (1987) Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear, Res. 30, 11-18.
59. Woolf, N.K. and Ryan, A.F. (1988) Contributions of the middle ear to the development of function of the cochlea. Hear. Res. 35, 131-142.